Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov;30(14):9-12.
doi: 10.3201/eid3014.240305.

Global Emerging Infections Surveillance Program Contributions to Pandemic Preparedness and Response

Review

Global Emerging Infections Surveillance Program Contributions to Pandemic Preparedness and Response

Kathleen E Creppage et al. Emerg Infect Dis. 2024 Nov.

Abstract

Since its establishment in 1997, the US Department of Defense (DoD) Global Emerging Infections Surveillance (GEIS) program has provided support for infectious disease pandemic preparedness and response. The GEIS program has shown the value of having a central hub responsible for coordinating a global network of DoD laboratories that conduct surveillance for militarily relevant infectious disease threats. The program has supported the establishment and maintenance of capabilities for collecting, characterizing, and reporting on major infectious disease events, including the COVID-19 pandemic and mpox outbreak. The GEIS program enables the US government to mitigate infectious disease threats to DoD mission readiness and to effectively respond to pathogens worldwide. Continued investment in maintaining the GEIS program and its network is critical for timely detection and response to future emerging infectious disease threats in various populations within locations where gaps in US government or host-nation surveillance might exist.

Keywords: COVID-19; DOD; Department of Defense; GEIS; Global Emerging Infections Surveillance Program; SARS; SARS-CoV-2; United States; coronavirus; coronavirus disease; pandemic; pandemic preparedness; pandemic response; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

PubMed Disclaimer

Figures

Figure
Figure
Timeline of key Department of Defense Global Emerging Infections Surveillance program events in support of pandemic preparedness and response, United States. Boxes and text indicate critical activities that occurred on or within specific time points. Time points were selected if multiple activities occurred within a several year period. Surveillance program was established in 1997 and has supported and continues to support multiple pandemic and outbreak responses, beginning with pandemic influenza. Key events in the GEIS program history are indicated where the program office or its partners provided support for infectious disease outbreak response or pandemic preparedness activities, including sequencing of samples to better characterize infectious disease threats as they emerged. GEIS, Global Emerging Infections Surveillance; MPXV, monkeypox virus.

Similar articles

  • The Central Role of the Global Emerging Infections Surveillance Program in Supporting Force Health Protection.
    Early JM, Smith HJ, Cinkovich SS, Gallaway MS, Stager CN, Kasper MR. Early JM, et al. Emerg Infect Dis. 2024 Oct;30(14):3-8. doi: 10.3201/eid3014.240304. Emerg Infect Dis. 2024. PMID: 39530772 Free PMC article.
  • Next-Generation Sequencing and Bioinformatics Consortium Approach to Genomic Surveillance.
    Morton LC, Rahman N, Bishop-Lilly KA. Morton LC, et al. Emerg Infect Dis. 2024 Oct;30(14):13-18. doi: 10.3201/eid3014.240306. Emerg Infect Dis. 2024. PMID: 39530777 Free PMC article.
  • Department of Defense influenza and other respiratory disease surveillance during the 2009 pandemic.
    Burke RL, Vest KG, Eick AA, Sanchez JL, Johns MC, Pavlin JA, Jarman RG, Mothershead JL, Quintana M, Palys T, Cooper MJ, Guan J, Schnabel D, Waitumbi J, Wilma A, Daniels C, Brown ML, Tobias S, Kasper MR, Williams M, Tjaden JA, Oyofo B, Styles T, Blair PJ, Hawksworth A, Montgomery JM, Razuri H, Laguna-Torres A, Schoepp RJ, Norwood DA, Macintosh VH, Gibbons T, Gray GC, Blazes DL, Russell KL; AFHSC-GEIS Influenza Surveillance Writing Group; Rubenstein J, Hathaway K, Gibbons R, Yoon IK, Saunders D, Gaywee J, Stoner M, Timmermans A, Shrestha SK, Velasco JM, Alera MT, Tannitisupawong D, Myint KS, Pichyangkul S, Woods B, Jerke KH, Koenig MG, Byarugaba DK, Mangen FW, Assefa B, Williams M, Brice G, Mansour M, Pimentel G, Sebeny P, Talaat M, Saeed T, Espinosa B, Faix D, Maves R, Kochel T, Smith J, Guerrero A, Maupin G, Sjoberg P, Duffy M, Garner J, Canas L, Macias E, Kuschner RA, Shanks D, Lewis S, Nowak G, Ndip LM, Wolfe N, Saylors K. Burke RL, et al. BMC Public Health. 2011 Mar 4;11 Suppl 2(Suppl 2):S6. doi: 10.1186/1471-2458-11-S2-S6. BMC Public Health. 2011. PMID: 21388566 Free PMC article. Review.
  • Training initiatives within the AFHSC-Global Emerging Infections Surveillance and Response System: support for IHR (2005).
    Otto JL, Baliga P, Sanchez JL, Johns MC, Gray GC, Grieco J, Lescano AG, Mothershead JL, Wagar EJ, Blazes DL; AFHSC-GEIS Training Writing Group; Achila R, Baker W, Blair P, Brown M, Bulimo W, Byarugaba D, Coldren R, Cooper M, Ducatez M, Espinosa B, Ewings P, Guerrero A, Hawksworth T, Jackson C, Klena JD, Kraus S, Macintosh V, Mansour M, Maupin G, Maza J, Montgomery J, Ndip L, Pavlin J, Quintana M, Richard W, Rosenau D, Saeed T, Sinclair L, Smith I, Smith J, Styles T, Talaat M, Tobias S, Vettori J, Villinski J, Wabwire-Mangen F. Otto JL, et al. BMC Public Health. 2011 Mar 4;11 Suppl 2(Suppl 2):S5. doi: 10.1186/1471-2458-11-S2-S5. BMC Public Health. 2011. PMID: 21388565 Free PMC article. Review.
  • Global Infectious Disease Surveillance at DoD Overseas Laboratories, 1999-2007.
    Sueker JJ, Chretien JP, Gaydos JC, Russell KL. Sueker JJ, et al. Am J Trop Med Hyg. 2010 Jan;82(1):23-7. doi: 10.4269/ajtmh.2010.09-0139. Am J Trop Med Hyg. 2010. PMID: 20064990 Free PMC article.

References

    1. US Department of Defense. Summary of 2018. national defense strategy of the United States of America [cited 2023 Dec 28]. https://DOD.defense.gov/Portals/1/Documents/pubs/2018-National-Defense-S...
    1. US Department of Defense. National biodefense strategy and implementation plan. October 2022. [cited 2024 Jan 2]. https://www.whitehouse.gov/wp-content/uploads/2022/10/National-Biodefens...
    1. Kasper MR, Geibe JR, Sears CL, Riegodedios AJ, Luse T, Von Thun AM, et al. An outbreak of Covid-19 on an aircraft carrier. N Engl J Med. 2020;383:2417–26. 10.1056/NEJMoa2019375 - DOI - PMC - PubMed
    1. Legendre BW, Boltz J, Riegodedios AJ, Brown AM, Kaplan MR, Feinberg JH, et al. Seroepidemiologic investigation of a COVID-19 outbreak aboard a U.S. Navy ship. MSMR. 2022;29:2–10. - PubMed
    1. The White House, Office of Science and Technology Policy. Presidential Decision Directive: fact sheet addressing the threat of emerging infectious diseases. June 12, 1996. [cited 2024 Jan 2]. https://irp.fas.org/offdocs/pdd_ntsc7.htm

MeSH terms

LinkOut - more resources